301 related articles for article (PubMed ID: 19549921)
1. ADAM23 negatively modulates alpha(v)beta(3) integrin activation during metastasis.
Verbisck NV; Costa ET; Costa FF; Cavalher FP; Costa MD; Muras A; Paixão VA; Moura R; Granato MF; Ierardi DF; Machado T; Melo F; Ribeiro KB; Cunha IW; Lima VC; Maciel Mdo S; Carvalho AL; Soares FF; Zanata S; Sogayar MC; Chammas R; Camargo AA
Cancer Res; 2009 Jul; 69(13):5546-52. PubMed ID: 19549921
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic silencing of the adhesion molecule ADAM23 is highly frequent in breast tumors.
Costa FF; Verbisck NV; Salim AC; Ierardi DF; Pires LC; Sasahara RM; Sogayar MC; Zanata SM; Mackay A; O'Hare M; Soares F; Simpson AJ; Camargo AA
Oncogene; 2004 Feb; 23(7):1481-8. PubMed ID: 14661055
[TBL] [Abstract][Full Text] [Related]
3. Combination of integrin siRNA and irradiation for breast cancer therapy.
Cao Q; Cai W; Li T; Yang Y; Chen K; Xing L; Chen X
Biochem Biophys Res Commun; 2006 Dec; 351(3):726-32. PubMed ID: 17087916
[TBL] [Abstract][Full Text] [Related]
4. The role of adhesion molecules, alpha v beta 3, alpha v beta 5 and their ligands in the tumor cell and endothelial cell adhesion.
Niu JX; Zhang WJ; Ye LY; Wu LQ; Zhu GJ; Yang ZH; Grau GE; Lou JN
Eur J Cancer Prev; 2007 Dec; 16(6):517-27. PubMed ID: 18090124
[TBL] [Abstract][Full Text] [Related]
5. Methylation profile of genes CDKN2A (p14 and p16), DAPK1, CDH1, and ADAM23 in head and neck cancer.
Calmon MF; Colombo J; Carvalho F; Souza FP; Filho JF; Fukuyama EE; Camargo AA; Caballero OL; Tajara EH; Cordeiro JA; Rahal P
Cancer Genet Cytogenet; 2007 Feb; 173(1):31-7. PubMed ID: 17284367
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of disintegrin-metalloproteinases ADAM-15 and ADAM-9 following upregulation of integrins alpha5beta1 and alphavbeta3 in atherosclerosis.
Al-Fakhri N; Wilhelm J; Hahn M; Heidt M; Hehrlein FW; Endisch AM; Hupp T; Cherian SM; Bobryshev YV; Lord RS; Katz N
J Cell Biochem; 2003 Jul; 89(4):808-23. PubMed ID: 12858346
[TBL] [Abstract][Full Text] [Related]
7. ADAM23 is downregulated in side population and suppresses lung metastasis of lung carcinoma cells.
Ota M; Mochizuki S; Shimoda M; Abe H; Miyamae Y; Ishii K; Kimura H; Okada Y
Cancer Sci; 2016 Apr; 107(4):433-43. PubMed ID: 26800504
[TBL] [Abstract][Full Text] [Related]
8. Beta(3) integrin expression increases breast carcinoma cell responsiveness to the malignancy-enhancing effects of osteopontin.
Furger KA; Allan AL; Wilson SM; Hota C; Vantyghem SA; Postenka CO; Al-Katib W; Chambers AF; Tuck AB
Mol Cancer Res; 2003 Sep; 1(11):810-9. PubMed ID: 14517343
[TBL] [Abstract][Full Text] [Related]
9. Expression and activation of alpha v beta 3 integrins by SDF-1/CXC12 increases the aggressiveness of prostate cancer cells.
Sun YX; Fang M; Wang J; Cooper CR; Pienta KJ; Taichman RS
Prostate; 2007 Jan; 67(1):61-73. PubMed ID: 17034033
[TBL] [Abstract][Full Text] [Related]
10. The mechanisms and dynamics of (alpha)v(beta)3 integrin clustering in living cells.
Cluzel C; Saltel F; Lussi J; Paulhe F; Imhof BA; Wehrle-Haller B
J Cell Biol; 2005 Oct; 171(2):383-92. PubMed ID: 16247034
[TBL] [Abstract][Full Text] [Related]
11. Integrin beta 3 cDNA transfection into a highly metastatic alpha v beta 3-negative human melanoma cell line inhibits invasion and experimental metastasis.
Danen EH; van Kraats AA; Cornelissen IM; Ruiter DJ; van Muijen GN
Biochem Biophys Res Commun; 1996 Sep; 226(1):75-81. PubMed ID: 8806594
[TBL] [Abstract][Full Text] [Related]
12. ADAM15 suppresses cell motility by driving integrin alpha5beta1 cell surface expression via Erk inactivation.
Chen Q; Meng LH; Zhu CH; Lin LP; Lu H; Ding J
Int J Biochem Cell Biol; 2008; 40(10):2164-73. PubMed ID: 18387333
[TBL] [Abstract][Full Text] [Related]
13. Secreted phosphoprotein 1 (SPP1, osteopontin) binds to integrin alpha v beta 6 on porcine trophectoderm cells and integrin alpha v beta 3 on uterine luminal epithelial cells, and promotes trophectoderm cell adhesion and migration.
Erikson DW; Burghardt RC; Bayless KJ; Johnson GA
Biol Reprod; 2009 Nov; 81(5):814-25. PubMed ID: 19571258
[TBL] [Abstract][Full Text] [Related]
14. Dendritic cell expression of ADAM23 governs T cell proliferation and cytokine production through the α(v)β(3) integrin receptor.
Elizondo DM; Andargie TE; Marshall KM; Zariwala AM; Lipscomb MW
J Leukoc Biol; 2016 Nov; 100(5):855-864. PubMed ID: 27317750
[TBL] [Abstract][Full Text] [Related]
15. The relationship between bone metastasis from human breast cancer and integrin alpha(v)beta3 expression.
Takayama S; Ishii S; Ikeda T; Masamura S; Doi M; Kitajima M
Anticancer Res; 2005; 25(1A):79-83. PubMed ID: 15816522
[TBL] [Abstract][Full Text] [Related]
16. Evidence for a differential functional regulation of the two beta(3)-integrins alpha(V)beta(3) and alpha(IIb)beta(3).
Ahrens IG; Moran N; Aylward K; Meade G; Moser M; Assefa D; Fitzgerald DJ; Bode C; Peter K
Exp Cell Res; 2006 Apr; 312(6):925-37. PubMed ID: 16434034
[TBL] [Abstract][Full Text] [Related]
17. Expression of alpha V integrin is modulated by Epstein-Barr virus nuclear antigen 3C and the metastasis suppressor Nm23-H1 through interaction with the GATA-1 and Sp1 transcription factors.
Choudhuri T; Verma SC; Lan K; Robertson ES
Virology; 2006 Jul; 351(1):58-72. PubMed ID: 16631833
[TBL] [Abstract][Full Text] [Related]
18. JWA regulates melanoma metastasis by integrin alphaVbeta3 signaling.
Bai J; Zhang J; Wu J; Shen L; Zeng J; Ding J; Wu Y; Gong Z; Li A; Xu S; Zhou J; Li G
Oncogene; 2010 Feb; 29(8):1227-37. PubMed ID: 19946336
[TBL] [Abstract][Full Text] [Related]
19. Interaction of human Thy-1 (CD 90) with the integrin alphavbeta3 (CD51/CD61): an important mechanism mediating melanoma cell adhesion to activated endothelium.
Saalbach A; Wetzel A; Haustein UF; Sticherling M; Simon JC; Anderegg U
Oncogene; 2005 Jul; 24(29):4710-20. PubMed ID: 15897908
[TBL] [Abstract][Full Text] [Related]
20. A tumor-protective role for human kallikrein-related peptidase 6 in breast cancer mediated by inhibition of epithelial-to-mesenchymal transition.
Pampalakis G; Prosnikli E; Agalioti T; Vlahou A; Zoumpourlis V; Sotiropoulou G
Cancer Res; 2009 May; 69(9):3779-87. PubMed ID: 19383923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
